HSPA1A and cancer: Nuclear and cytoplasmic HSP70 expression gradually decreased from Masaoka-Koga tumor stage I to IV, indicating that a decrease of HSP70 expression goes along with increasing malignant tumor invasiveness and worse prognosis.